Taurolidine group (n = 60) | Control group (n = 60) | P | |
---|---|---|---|
Adjuvant chemotherapy | 14 | 21 | .11 |
Colon cancer | 11 | 10 | - |
Gastric cancer | 1 | 7 | 0.02 |
Pancreatic cancer | 2 | 4 | - |
Adjuvant radiotherapy | 9 | 7 | 0.39 |
Colon cancer | 7 | 6 | - |
Gastric cancer | 2 | 1 | - |
Pancreatic cancer | - | - | - |
Follow-up* (months) | 50.0 (1.7–72.0) | ||
Colon cancer | 53.5 (9.0–72.1) | 59.2 (19.6–72.0) | 0.41 |
Gastric cancer | 39.9 (1.7–72.0) | 43.7 (5.7–67.3) | 0.84 |
Pancreatic cancer | 15.6 (8.5–34.5) | 10.7 (8.8–46.9) | 0.66 |
Overall tumour recurrence rate | 19 | 22 | 0.35 |
Type of recurrence | |||
Loco-regional recurrence rate | 7 | 12 | 0.16 |
Colon cancer | 2 | 4 | 0.32 |
Gastric cancer | 3 | 5 | 0.35 |
Pancreatic cancer | 2 | 3 | 0.61 |
Time to local recurrence* (months) | 17.8 (5.6–35.6) | 16.0 (5.3–26.5) | 0.43 |
Colon cancer | 10.9 and 35.6 | 18.4 (6.0) | 1 |
Gastric cancer | 18.2 (2.9) | 14.9 (4.4) | 0.39 |
Pancreatic cancer | 5.6 and 21.3 | 10.8 (7.0) | 0.8 |
Distant metastasis rate | 13 | 18 | 0.2 |
Colon cancer | 6 | 8 | 0.35 |
Gastric cancer | 4 | 6 | 0.36 |
Pancreatic cancer | 3 | 4 | 0.65 |
Time to metastasis * (months) | 21.0 (5.2–44.5) | 14.4 (3.0–35.9) | 0.17 |
Colon cancer | 23.7 (11.4–44.5) | 19.3 (3.0–35.9) | 0.28 |
Gastric cancer | 16.5 (5.2–34.1) | 14.0 (5.9–24.1) | 0.76 |
Pancreatic cancer | 22.3 (12.3–24.0) | 12.3 (4.0–18.6) | 0.23 |
Overall mortality rate | 28 | 25 | 0.36 |
Colon cancer | 8 | 7 | 0.53 |
Gastric cancer | 15 | 12 | 0.29 |
Pancreatic cancer | 5 | 6 | - |
Time to death * (months) | 20.0 (0.1–61.0) | 19.6 (0.1–58.5) | 0.71 |
Colon cancer | 35.6 (9.0–61.0) | 22.1 (0.1–58.5) | 0.34 |
Gastric cancer | 12.8 (0.1–58.6) | 12.4 (0.8–40.1) | 0.65 |
Pancreatic cancer | 15.6 (8.5–34.5) | 10.5 (0.8–46.9) | 0.66 |
Causes of death | |||
Cancer-related mortality rate | 17 | 19 | 0.2 |
Colon cancer | 6 | 6 | - |
Gastric cancer | 6 | 8 | 0.22 |
Pancreatic cancer | 5 | 5 | - |
Perioperative mortality | 2 | 3 | 0.5 |
Others | 9 | 3 | |
Tumour progression | 15 | 16 |